The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Patients with PsA, Cutaneous Psoriasis May Undergo Hip Replacement

Patients with PsA, Cutaneous Psoriasis May Undergo Hip Replacement

July 15, 2016 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

1shutterstock_HipBone_500x270Rheumatologists concerned about their patients with psoriatic arthritis and cutaneous psoriasis who are considering a hip replacement can rest assured: neither disease is a risk factor for worse outcomes after total hip arthroplasty, according to the lead author of a study published in Arthritis & Rheumatology.

You Might Also Like
  • Hip-Resurfacing Arthroplasty an Alternative to Total Hip Replacement
  • Patients with Mental Illness Fare Worse after Hip Surgery
  • Patients with Psoriasis, Psoriatic Arthritis at Increased Risk of Migraine
Also By This Author
  • Complex Treatment: Cancer, Immunotherapy & Rheumatic Disease

The results, published in an article titled “Short-Term Total Hip Arthroplasty Outcomes in Patients with Psoriatic Arthritis or Psoriatic Skin Disease Compared to Patients with Osteoarthritis,” actually surprised its lead author, Lisa A. Mandl, MD, MPH, a rheumatologist at the Hospital for Special Surgery and assistant research professor at Weill Cornell, both in New York City.1

Lisa A. Mandl, MD, MPH

Lisa A. Mandl, MD, MPH

“When we saw the final results—really no differences between patients with osteoarthritis, skin psoriasis or inflammatory psoriatic arthritis in their results after they have the hip replaced—I was happy to be proven wrong,” says Dr. Mandl. “We were concerned that the inflammation associated with psoriatic arthritis, and [patients’] tendency to build bone, might make [those patients] more prone to worse outcomes. However, this was not the case.”

According to the article, investigators examined two years of self-reported data for 153 validated cases of psoriatic arthritis and cutaneous psoriasis, all cases matched with patients with osteoarthritis as controls. No significant differences were found in pre- or postoperative Western Ontario and McMaster Universities OA Index scores for pain or function between the three groups. In regression analyses, neither psoriatic arthritis nor cutaneous psoriasis was a risk factor for worse outcomes after total hip arthroplasty. Also, patient satisfaction was high among all three groups (P=0.54).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Psoriatic arthritis affects more than 7 million Americans and can be difficult to diagnose, Dr. Mandl says, because it often affects relatively young and otherwise healthy patients. Some patients initially relate arthritis pain to sports injuries or overuse and, “therefore, are late coming to medical attention.”

“It’s very encouraging to be able to tell our patients who have psoriatic arthritis and end-stage damage to their hips that if they choose to have the hip replaced they should do very well,” Dr. Mandl says. “[For clinicians], there is no reason to discourage patients with psoriatic arthritis from having their hip replaced if they need it, as they will do equally well as patients with osteoarthritis who we know have excellent outcomes.”

Richard Quinn is a freelance writer in New Jersey.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. Mandl LA, Zhu R, Huang WT, et al. Short-term total hip arthroplasty outcomes in patients with psoriatic arthritis or psoriatic skin disease compared to patients with osteoarthritis. Arthritis Rheumatol. 2016 Feb;68(2):410–417. doi: 10.1002/art.39431.

Pages: 1 2 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: Arthritis & Rheumatology, hip, hip arthroplasty, hip replacement, Psoriasis, psoriatic arthritis

You Might Also Like:
  • Hip-Resurfacing Arthroplasty an Alternative to Total Hip Replacement
  • Patients with Mental Illness Fare Worse after Hip Surgery
  • Patients with Psoriasis, Psoriatic Arthritis at Increased Risk of Migraine
  • Ibuprofen an Option for Early Pain Control after Hip Replacement

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.